Risk of bias graph. by Ziyi Li (349831)

Subjects:

Risk of bias summary. by Ziyi Li (349831)

Subjects:

Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO). by Marina Wainstein (12437091)

Effect of different polyunsaturated fatty acids (PUFAs) in the inhibition of HCoV-229Eviral replication in MRC5 cells using antibody-based assay demonstrates significant inhibition... by Amanda Watson (4447267)

A visual depiction of the system dynamics model used to model threat increases and decreases as functions of stimulus and habituation. by Josh Bullock (15195287)

Logistic regression: Risk factors for PTB <35w in subsequent delivery. by Gal Cohen (12536546)

Subjects:

Risk Classification Diagram of Hot Surface. by Lei Bai (631944)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Sample characteristics of survey respondents. by Fabrice Etilé (4741332)

Subjects:

Effect heterogeneity by trust and family orientation. by Fabrice Etilé (4741332)

Subjects:

Distribution of status anxiety scores. by Fabrice Etilé (4741332)

Subjects:

Beliefs about COVID-19. by Fabrice Etilé (4741332)

Subjects:

Kaplan-Meier curves for time until depression/anxiety stratified by OM, WLR, and WLM. by G. Craig Wood (7522025)

Subjects:

Overview of study design and timeline. by G. Craig Wood (7522025)

Subjects:

Kaplan-Meier curves for time until cancer stratified by sex and OM, WLR, and WLM. by G. Craig Wood (7522025)

Subjects:

Poisson Regression for days with healthcare utilization visits per year compared within Weight Loss Maintainers. by G. Craig Wood (7522025)

Subjects:

Baseline descriptive statistics of the study population. by G. Craig Wood (7522025)

Subjects:

Adjusted Cox regression model for time until health-related outcomes. by G. Craig Wood (7522025)

Subjects:

Kaplan-Meier curves for time until osteoarthritis within the WLM group stratified by the amount of weight loss at the end of the 2+ year index period. by G. Craig Wood (7522025)

Subjects: